Report
Hugo Solvet

VOLUNTIS Departure of Scott Honken, VP Payers Sales & Strategy

Scott Honken, Senior VP Payers Sales & Strategy left Voluntis
Continuation of the WellDyneRx deal
We see limited execution risk (i.e. ability to ink new contracts)
Ongoing partnership with Livongo
Adj. ests. to reflect time to implement Insulia in payers offer
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Hugo Solvet

ResearchPool Subscriptions

Get the most out of your insights

Get in touch